|
Recent Newsletters
News Alert: FDA approves first cellular therapy to treat type 1 diabetes |
Economics Highlights: Doc agrees to pay $5M | A new class-action lawsuit | Colchicine for CVD: What will it cost? |
Balloon-expandable vs. self-expandable TAVR valves | Cardiologist the highest-paying job in 2 states | IVL for TLE |
What will Lodoco cost? Looking ahead after FDA’s colchicine approval | A new catheter recall | Cyberattack leads to lawsuit |
News Alert: FDA announces new recall of interventional devices due to risk of catheter separation |
Care Delivery Highlights: Top 20 children’s hospitals for cardiology | Surgeon racks up 21 malpractice settlements |
VR during TAVR | Cardiologists applaud FDA’s colchicine approval | Abbott awards $2.6M to ADA |